HHS Secretary Kennedy Jr. Slashes 3500 FDA and 2400 CDC Jobs

HHS Secretary Robert F. Kennedy Jr. announced plans to cut 3500 full-time staff from the FDA and 2400 from the CDC this week. The drastic reductions aim to streamline the agencies amid President Trumps push for government efficiency. Critics warn the move could weaken public health oversight at a critical time.

Kennedy framed the cuts as a necessary step to root out waste and corporate influence in the health sector. He has long criticized the FDA and CDC for cozy ties with Big Pharma and poor performance on chronic disease. The layoffs targeting roughly 15 percent of each agencys workforce signal a bold shift in priorities.

The FDA oversees drug approvals and food safety while the CDC tracks diseases and sets vaccine policies. Losing 3500 FDA staff could slow reviews of new treatments already a lengthy process. Similarly slashing 2400 CDC jobs may hamper outbreak response as measles cases rise in parts of the U.S.

Trump praised Kennedys plan as part of his broader DOGE initiative led by Elon Musk to shrink federal bureaucracy. The President argues bloated agencies burden taxpayers with little benefit. Supporters say the cuts will force a focus on core missions over unnecessary red tape.

Health experts express alarm over the timing with childhood vaccination rates dropping nationwide. They fear fewer staff could delay critical updates to safety standards or disease tracking. Some predict legal challenges if the cuts disrupt mandated functions of either agency.

Kennedy insists the reductions will target bureaucrats not scientists though details remain scarce. He has vowed to redirect resources toward nutrition and preventive health over pharmaceutical reliance. Skeptics question how such ambitious goals can succeed with a leaner workforce.

Congressional Democrats have blasted the plan as reckless promising oversight hearings to assess the impact. They argue gutting the FDA and CDC risks public safety for ideological gains. Republicans counter that bold action is overdue to fix agencies they see as inefficient and overreaching.

The cuts come as Kennedy settles into his role after a contentious Senate confirmation in February. His Make America Healthy Again agenda now faces its first major test. How these reductions play out could define his tenure—and Trumps health policy legacy—for years to come.